Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3135 (LINC03135) is a long non-coding RNA gene expressed in humans[1][3][5][7]. As part of the lincRNA family, it does not code for a protein and is thought to contribute to regulation of gene expression by acting at various levels, such as epigenetic, transcriptional, and post-transcriptional regulation[2][9]. The lincRNA class is generally implicated in cell proliferation, apoptosis, and has tissue-specific regulatory functions, though there is currently no published evidence for disease-specific roles, interacting drugs, or biomarker utility for this particular lincRNA. The primary aliases for this gene include AL033519.3 and RP3-340B19.3[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3135 (LINC03135).